1,209 results on '"Howes, Oliver D."'
Search Results
2. Mitochondrial complex I density is associated with IQ and cognition in cognitively healthy adults: an in vivo [18F]BCPP-EF PET study
3. Schizophrenia: from neurochemistry to circuits, symptoms and treatments
4. Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study
5. Correction: Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study
6. Mesostriatal Dopaminergic Circuit Dysfunction in Schizophrenia: A Multimodal Neuromelanin-Sensitive Magnetic Resonance Imaging and [18F]-DOPA Positron Emission Tomography Study
7. New Drug Treatments for Schizophrenia: A Review of Approaches to Target Circuit Dysfunction
8. A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression
9. Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice
10. The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment
11. The synaptic hypothesis of schizophrenia version III: a master mechanism
12. Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study
13. Synaptic Terminal Density Early in the Course of Schizophrenia: An In Vivo UCB-J Positron Emission Tomographic Imaging Study of SV2A
14. Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysis
15. Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration
16. Antidepressant and antipsychotic side-effects and personalised prescribing: a systematic review and digital tool development
17. Data-Driven Taxonomy for Antipsychotic Medication: A New Classification System
18. Shared and separate patterns in brain morphometry across transdiagnostic dimensions
19. Predicting treatment resistance from first-episode psychosis using routinely collected clinical information
20. Neuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes
21. Brain volume in chronic ketamine users — relationship to sub-threshold psychotic symptoms and relevance to schizophrenia
22. Adenosine A2A receptor in schizophrenia: an in vivo brain PET imaging study
23. The association between peripheral inflammation, brain glutamate and antipsychotic response in Schizophrenia: Data from the STRATA collaboration
24. The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research.
25. Multi-omics data integration methods and their applications in psychiatric disorders
26. Effect of polygenic risk for schizophrenia on cardiac structure and function: a UK Biobank observational study
27. The effects of AUT00206, a novel Kv3.1/3.2 potassium channel modulator, on task-based reward system activation: a test of mechanism in schizophrenia
28. The relationship between glutamate, dopamine, and cortical gray matter: A simultaneous PET-MR study
29. Reward processing in schizophrenia and its relation to Mu opioid receptor availability and negative symptoms: A [11C]-carfentanil PET and fMRI study
30. A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia
31. Striatal dopamine synthesis capacity and its association with negative symptoms upon resolution of positive symptoms in first-episode schizophrenia and delusional disorder
32. White-matter free-water diffusion MRI in schizophrenia: a systematic review and meta-analysis
33. The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study
34. Efficacy and safety of Lu AF35700 in treatment-resistant schizophrenia: A randomized, active-controlled trial with open-label extension
35. Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art
36. Impaired verbal memory function is related to anterior cingulate glutamate levels in schizophrenia: findings from the STRATA study
37. Polygenic heterogeneity in antidepressant treatment and placebo response
38. A cross-sectional MR study of body fat volumes and distribution in chronic schizophrenia
39. Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
40. A polygenic score indexing a DRD2-related co-expression network is associated with striatal dopamine function
41. The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across waves
42. New and emerging treatments for schizophrenia: a narrative review of their pharmacology, efficacy and side effect profile relative to established antipsychotics
43. Cell line specific alterations in genes associated with dopamine metabolism and signaling in midbrain dopaminergic neurons derived from 22q11.2 deletion carriers with elevated dopamine synthesis capacity
44. Correction: Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study
45. Treatment resistance in psychiatry: state of the art and new directions
46. Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology
47. Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data
48. Corrigendum: The effect of antipsychotics on glutamate levels in the anterior cingulate cortex and clinical response: a 1H-MRS study in first-episode psychosis patients
49. Histamine-3 Receptor Availability and Glutamate Levels in the Brain: A PET-1H-MRS Study of Patients With Schizophrenia and Healthy Controls
50. Immune response to vaccination in people with psychotic disorders relative to healthy controls: prospective study of SARS-CoV-2 vaccination
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.